Rushford at Cheshire

Rushford at Cheshire

Services:
Facility Vaping Policy
• Vaping permitted in designated area

Facility Operation (e.g., Private, Public)

• Private non-profit organization

Pharmacotherapies

• Nicotine replacement
• Non-nicotine smoking/tobacco cessation
• Buprenorphine without naloxone
• Disulfiram
• Naltrexone (oral)
• Buprenorphine with naloxone
• Medication for mental disorders
• Clonidine
• Naltrexone (extended-release, injectable)
• Acamprosate (Campral®)
• Lofexidine

Type of Care

• Substance use treatment
• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

Education and Counseling Services

• Substance use disorder education
• Group counseling
• Individual counseling
• Family counseling

Recovery Support Services

• Assistance with obtaining social services
• Housing services
• Self-help groups
• Mentoring/peer support
• Recovery coach

Hospitals

• General Hospital (including VA hospital)

Payment/Insurance/Funding Accepted

• Cash or self-payment
• Medicaid
• Private health insurance

License/Certification/Accreditation

• Drug Enforcement Agency (DEA)
• State mental health department
• The Joint Commission
• State department of health

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

Transitional Services

• Discharge Planning
• Naloxone and overdose education
• Aftercare/continuing care
• Outcome follow-up after discharge

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Outpatient
• Outpatient methadone/buprenorphine or naltrexone treatment
• Regular outpatient treatment
• Intensive outpatient treatment
• Outpatient day treatment or partial hospitalization

External Opioid Medications Source

• No formal relationship with prescribing entity
• In-network prescribing entity

Age Groups Accepted

• Adults
• Young Adults

External Source of Medications Used for Alcohol Use Disorder Treatment

• No formal relationship with prescribing entity
• In-network prescribing entity

Type of Opioid Treatment

• Relapse prevention with naltrexone
• Prescribes buprenorphine
• Prescribes naltrexone
• Accepts clients using MAT but prescribed elsewhere
• Maintenance service with medically supervised withdrawal after stabilization
• Buprenorphine maintenance

Treatment Approaches

• Anger management
• Trauma-related counseling
• Cognitive behavioral therapy
• Motivational interviewing
• Relapse prevention
• Substance use disorder counseling
• Telemedicine/telehealth therapy

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder
• Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere

Facility Smoking Policy

• Smoking permitted in designated area

Testing

• Drug or alcohol urine screening
• Breathalyzer or blood alcohol testing

Ancillary Services

• Mental health services
• Suicide prevention services

Special Programs/Groups Offered

• Clients with co-occurring mental and substance use disorders
• Clients who have experienced trauma
• Adult men
• Adult women

Language Services

• Sign language services for the deaf and hard of hearing

Gender Accepted

• Female
• Male

Assessment/Pre-treatment

• Professional interventionist/educational consultant
• Screening for tobacco use
• Screening for mental disorders
• Screening for substance use
• Comprehensive substance use assessment
• Outreach to persons in the community
• Comprehensive mental health assessment